Skip to main content
SpringerLink
Log in

The Formulary Decision-Making Process in a US Academic Medical Centre

  • Formulary Management
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

This article reviews and describes the formulary decision-making process in an academic medical centre. The pharmacy and therapeutics (P & T) committee is the organisational nucleus of the drug use control process in the institutional environment. Thomas Jefferson University Hospital (TJUH). a 720-bed academic medical centre in an urban locality in the US, is used as a model representative of how most of these committees function. Survey responses collected from 29 peer academic medical centres arc presented to compare and contrast the structure and function of the P & T committee at TJUH with corresponding procedures in other university hospitals in the US.

TJUH is typical of the institutions which comprise the University Hospital Consortium (UHC). The P & T committee of TJUH is composed of 29 members, meets once per month for 10 months of the year, and has a network of 13 subcommittees. TJUH has an intermediately controlled (mixed) formulary, and uses both restricted drugs and treatment guidelines. Of the 29 UHC member institutions responding to the survey. the average P & T membership is 18, the average meeting frequency is 11 times per year, and 83% of these committees have a network of subcommittees, None describe their formulary system as open, 86% have a closed formulary and 14% have a mixed formulary system. There is a restricted drug programme in 76% of the institutions, 79% utilise treatment guidelines, 76% practice therapeutic interchange and all employ generic substitution.

Specific areas addressed in this review include the history of the formulary system, the structure and function of the P & T committee, types of formularies, cost containment and the formulary decision-making process. the impact of organisational culture on physician decision making. the role of the pharmacy department, the role of pharmaceutical sales representatives and their impact on prescribing habits, the impact of the Joint Commission on Accreditation of Healthcare Organisations (JCAHO) Agenda for Change on the formulary process, and future challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abramowitz PW, Fletcher CV. Counterpoint: Let’s expand the formulary system and renew its vigor. American Journal of Hospital Pharmacy 43: 2834–2838, 1986

    PubMed  CAS  Google Scholar 

  • Achusim LE. Therapeutic interchange as a cost-containment measure. PharmacoEconomics 2: 347–351, 1992

    Article  PubMed  CAS  Google Scholar 

  • Adams TD, Burleson KW. Continuous quality improvement in a medication error reporting system. P&T 17: 943–952, 1992

    Google Scholar 

  • American College of Physicians. Position paper: therapeutic substitution and formulary systems. Annals of Internal Medicine 113: 160–163, 1990

    Google Scholar 

  • American Society of Hospital Pharmacists. ASHP statement on the formulary system, American Journal of Hospital Pharmacy 43: 2839–2841, 1986a

  • American Society of Hospital Pharmacists. ASHP statement on the pharmacy and therapeutics committee. American Journal of Hospital Pharmacy 43: 2841–2842, 1986b

  • American Society of Hospital Pharmacists. The formulary system: brief history and 1960’s perspective. American Journal of Hospital Pharmacy 43: 2838–2839, 1986c

  • American Society of Hospital Pharmacists. Practice standards of ASHP 1991–1992, American Society of Hospital Pharmacists, Bethesda. Maryland. 1991

  • Ault A. Drug utilization review: apocalypse when? Medicine and Health Perspectives 24: 1–4, 1992

    Google Scholar 

  • Avorn J, Soumerai SB. Improving drug therapy decisions through educational outreach: randomized controlled trial of academically based detailing. New England Journal of Medicine 308: 1457–1463, 1983

    Article  PubMed  CAS  Google Scholar 

  • Avorn J, Harvey K, Soumerai SB. Information and education as determinants of antibiotic use: report of task force 5. Reviews of Infectious Diseases 9 (Suppl. 3): S286–S296, 1987

    Google Scholar 

  • Bamberger DM, Dahl SL. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a leaching hospital. Archives of Internal Medicine 152: 554–557, 1992

    Article  PubMed  CAS  Google Scholar 

  • Bootman JL, Townsend RJ, McGhan WF. Principles of Pharmacoeconomics, Harvey Whitney Books Company, Cincinnati, Ohio 1991

    Google Scholar 

  • Brown CH. Physician acceptance of drug-therapy recommendations using a written data and communications form. American Society of the Consultant Pharmacist 6: 729–734, 1991

    Google Scholar 

  • Cano SB, Fujita NK. Formulary evaluation of third-generation cephalosporins using decision analysis. American Journal of Hospital Pharmacy 45: 566–569, 1988

    PubMed  CAS  Google Scholar 

  • Cascio MV, Williams JM. Impact of a nonformulary drug notification form. American Journal of Hospital Pharmacy 39: 1039–1041, 1982

    PubMed  CAS  Google Scholar 

  • Chan J, Einarson TR. Drug detailing in the hospital: background for policy development. Canadian Journal of Hospital Pharmacy 44: 161–166, 1991

    PubMed  CAS  Google Scholar 

  • Cook AA, Sanchez ML. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary. Hospital Pharmacy 27: 867–882, 1992

    PubMed  CAS  Google Scholar 

  • Coppola P. A successful pharmacy-directed formulary restriction of H2-antagonists. American Society of Hospital Pharmacists, Annual Meeting 47, Boston, Abstract P-7D, 1990

    Google Scholar 

  • Curtiss FR. Pharmacy management strategies for responding to hospital reimbursement changes. American Journal of Hospital Pharmacy 40: 1489–1492, 1983

    PubMed  CAS  Google Scholar 

  • Daniels CE, Wertheimer AI. Analysis of hospital formulary effects on cost control. Topics in Hospital Pharmacy Management 2: 32–49, 1982

    PubMed  CAS  Google Scholar 

  • Davern PF, Kubiea AJ. Controlling drug costs: administrative and clinical strategies. Topics in Hospital Pharmacy Management 7: 48–58, 1987

    PubMed  CAS  Google Scholar 

  • Eisenberg J. Doctors decisions and the cost of medical care. Health Administration Press, Ann Arbor, Michigan, 1986

    Google Scholar 

  • Epstein AM. Changing physician behavior - increasing challenges for the 1990s. Archives of Internal Medicine 151: 2147–2149, 1991

    Article  PubMed  CAS  Google Scholar 

  • Gervase JS. Major antibiotic formulary changes: convincing the docs through clinical interventions and persuasion techniques. ASHP Midyear Clinical Meeting 25, Las Vegas, Abstract Pl–24, 1990

    Google Scholar 

  • Hennessy S, Strom BL. Issues in hospital-based drug use evaluation, P&T: 733–754, 1992

    Google Scholar 

  • Himmelberg CJ, Pleasants RA, Weber DJ, Kessler JM, Samsa GP, et al. Use of antimicrobial drugs in adults before and after removal of a restriction policy. American Journal of Hospital Pharmacy 48: 1220–1227, 1991

    PubMed  CAS  Google Scholar 

  • Hinnant JT, Grapes ZT. Formulary management activities in Georgia. ASHP Midyear Clinical Meeting 25, Las Vegas, Abstract P–94E, 1990

    Google Scholar 

  • Hinnant JT, Grapes ZT. Formulary management activities in Georgia. P&T 17: 475–478, 487-488, 1992

    Google Scholar 

  • Ioannides-Demos LL, Eckerl GM, McLean AJ. Phartnacoeconomic consequences of measurement and modification of hospital drug use. PharmacoEconomics 2: 15–33, 1992

    Article  PubMed  CAS  Google Scholar 

  • Joint Commission on Accreditation of Healthcare Organizations. Accreditation manual for hospitals 1992, Joint Commission on Accreditation of Healthcare Organizations, Chicago, Illinois, 1991

  • Kepler JA. Drug therapy review - coumarin and indandione derivatives. American Journal of Hospital Pharmacy 30: 705–713, 1973

    CAS  Google Scholar 

  • Kitlel JF, Swalzell RH, Williams MP. Forrester CW, Bancroft WH. Development or a flexible formulary for a Veterans Administration hospital. Hospital Formulary 13: 46–48, 1978

    Google Scholar 

  • Lawrenz C, Theodorou A, Cook R, Cole P. Formulary interchange: ampicillin/sulbactam for cefoxitin. Abstract of Meeting Presentation, ASHP Midyear Clinical Meeting 24, Atlanta, Abstract P–34D, 1989

    Google Scholar 

  • Lee HE. Coping with DRGs: Evanston hospital, Evanston, Illinois. American Journal of Hospital Pharmacy 40: 1508–1509, 1983

    PubMed  CAS  Google Scholar 

  • Lewis RP, Moore TD. P&T committee perspectives: achieving an effective committee through reorganization: the Ohio State University Hospital’s experience. Hospital Formulary 26: 120–124, 129-130, 1991

    PubMed  CAS  Google Scholar 

  • Lichstein PR, Turner RC, O’Brien K. Impact of pharmaceutical company representatives on internal medicine residency programs - a survey of residency program directors. Archives of Internal Medicine 152: 1009–1013, 1992

    Article  PubMed  CAS  Google Scholar 

  • Lingle EW, Reeder CE, Kozma CM. Impact of an open formulary system on the utilization of medical services. Journal of Research in Pharmaceutical Economics 2: 93–123, 1990

    Google Scholar 

  • Linkewich JA, Prevoznik SJ. Guidelines on the operation of the pharmacy and therapeutics committee and formulary. Hospital Pharmacy 14: 7–22, 1979

    PubMed  CAS  Google Scholar 

  • Lovly R. Total quality management and the P&T committee. P&T 17: 953–962, 1992

    Google Scholar 

  • Lumsdon K. As hospital drug budgets soar, pharmacy’s role is being rewritten. Hospitals 20: 34–40, 1992

    Google Scholar 

  • Lyon RA. Use of general (tertiary) reference sources in a university hospital based drug information service. Hospital Formulary 19: 210–218, 1984

    PubMed  CAS  Google Scholar 

  • McEvoy GK. Obtaining references for AHFS drug information monographs. American Journal of Hospital Pharmacy 44: 1552, 1987

    Google Scholar 

  • McEvoy GK. Unlabeled uses of drugs in AHFS drug information monographs. American Journal of Hospital Pharmacy 45: 1271–1272, 1988

    Google Scholar 

  • Mutnick AH, Barenfanger J, Szymusiak-Mutnick B. Use of a multidisciplinary educational program - an alternative to pharmacy-initiated directives. P&T 17: 867–883, 1992

    Google Scholar 

  • Myers CE, Pierpaoli PG, Smith MA. Measurement of formulary inclusion costs. Hospital Formulary 16: 951–976, 1981

    PubMed  CAS  Google Scholar 

  • Nash DB. Practice guidelines and outcomes - where are we headed? Archives of Pathology and Laboratory Medicine 114: 1122–1125, 1990

    PubMed  CAS  Google Scholar 

  • Nolte MJ, Sorrenlino AC, Ernst TF. Therapeutic drug class reviews: systematic evaluation of the hospital formulary. ASH P Annual Meeting 48, San Diego, Abstract MCS-13, 1991

    Google Scholar 

  • Osborne JA. Coping with DRGs: Baptist Medical Center of Oklahoma, Oklahoma City. American Journal of Hospital Pharmacy 40: 1506–1507, 1983

    PubMed  CAS  Google Scholar 

  • Pearce MJ, Begg EJ. A review of limited lists and formularies: are they cost-effective? Pharmacoeconomics 1: 191–202, 1992

    Article  PubMed  CAS  Google Scholar 

  • Price KO. Drug information center support of P&T commitlees - cost justification and fee-for-service activities. P&T 17: 632–641, 1992

    Google Scholar 

  • Roberts RW. Coping with DRGs: Riverside Hospital, Jacksonville. Florida. American Journal of Hospital Pharmacy 40: 1500–1502, 1983

    PubMed  CAS  Google Scholar 

  • Rucker TD. The formulary process as it relates to drug utilization review. P&T 17: 646–657, 1992

    Google Scholar 

  • Sangha KS, Gora ML, LeRoy ML. Innovative way of removing high use drugs from the formulary of a university leaching hospital. ASHP Annual Meeting 48. San Diego, Abstract P-77 D, 1991

    Google Scholar 

  • Sass CM, Ashworth LE. Role of a drug information center in formulary management. ASHP Annual Meeting 48, San Diego, Abstract P-9D, 1991

    Google Scholar 

  • Schumacher GE. Multiattribute evaluation in formulary decision making as applied to calcium-channel blockers. American Journal of Hospital Pharmacy 48: 301–308, 1991

    PubMed  CAS  Google Scholar 

  • Seltzer JL, Wordell CJ, Nash DB, Johnson NE, Gottlieb JE. P&T committee response to evolving technologies: preparing for the launch of high-tech, high-cost products. Hospital Formulary 27: 379–392, 1992

    PubMed  CAS  Google Scholar 

  • Sherman DS. Learning how to influence prescribing behavior. Contemporary Long Term Care 15(5): 70–84, 1992

    PubMed  CAS  Google Scholar 

  • Soumerai SB, Avorn J. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. Mil-bank Memorial Fund Quarterly/Health and Society 62: 447–474, 1984

    Article  CAS  Google Scholar 

  • Soumerai SB, Ross-Degnan D, Gortmakcr S, Avorn J. Withdrawing payment for nonsciemiflc drug therapy - intended and unexpected effects of a large scale natural experiment. Journal of the American Medical Association 263: 831–839, 1990

    Article  PubMed  CAS  Google Scholar 

  • Sutlers CA. Management of a hospital formulary. Journal or Clinical Pharmacy and Therapeutics 1: 1559–76, 1990

    Google Scholar 

  • Thomas J. National survey of hospital policies on pharmaceutical sales represenlalives’ activities. American Journal of Hospital Pharmacy 44: 1334–1340, 1987

    PubMed  Google Scholar 

  • Thomas J. National survey of recent changes in hospital policies on pharmaceutical sales representatives’ activities. American Journal of Hospital Pharmacy 46: 565–569, 1989

    PubMed  Google Scholar 

  • Thomas Jefferson University Hospital Policy and procedures manual, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 1992

  • Todd MW. Experience with a criteria-based formulary system. Florida Journal of Hospital Pharmacy 9: 29–37, 1989-1990

    Google Scholar 

  • Upton JH, Crouch JB, Douglas JB. Coping with DRGs: the Moses H. Cone Memorial Hospital. Greensboro. North Carolina. American Journal of Hospital Pharmacy 40: 1496–1499, 1983

    CAS  Google Scholar 

  • Weist CA, Falk D, Hancock BO, Molinari F. Drug information service directed formulary management: development of an oral potassium formulary. ASHP Annual Meeting 48, San Diego, Abstract P-I2D, 1991

    Google Scholar 

  • Zellmer WA. Rethinking the formulary system concept - introduction. American Journal of Hospital Pharmacy 43: 2829, 1986

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Policy and Clinical Outcomes, Thomas Jefferson University Hospital, 1015 Walnut Street, 621 Curtis, Philadelphia, Pennsylvania, 19107-5099, USA

    David B. Nash (Director)

  2. Center for Proper Medication Use, Philadelphia, Pennsylvania, USA

    Mary L. Catalano

  3. Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

    Cindy J. Wordell

Authors
  1. David B. Nash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary L. Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cindy J. Wordell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nash, D.B., Catalano, M.L. & Wordell, C.J. The Formulary Decision-Making Process in a US Academic Medical Centre. Pharmacoeconomics 3, 22–35 (1993). https://doi.org/10.2165/00019053-199303010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199303010-00004

Keywords

Search

Navigation